$GRTX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Galera Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Galera Therapeutics, Inc.. Get notifications about new insider transactions in Galera Therapeutics, Inc. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17 2021 | GRTX | Galera Therapeutic ... | West Linda | Director | Option Exercise | A | 8.90 | 9,888 | 88,003 | 9,888 | |
| Jun 17 2021 | GRTX | Galera Therapeutic ... | West Linda | Director | Buy | P | 9.13 | 10,000 | 91,300 | 40,000 | 30 K to 40 K (+33.33 %) |
| Jun 17 2021 | GRTX | Galera Therapeutic ... | POWELL MICHAEL | Director | Option Exercise | A | 8.90 | 13,179 | 117,293 | 13,179 | |
| Feb 19 2021 | GRTX | Galera Therapeutic ... | Novo Holdings A/S | 10% Owner | Sell | S | 10.58 | 500,000 | 5,290,000 | 2,459,021 | 3 M to 2.5 M (-16.90 %) |
| Jan 28 2021 | GRTX | Galera Therapeutic ... | Degnan Chris | Chief Financial Off ... | Option Exercise | A | 11.99 | 82,500 | 989,175 | 82,500 | |
| Nov 16 2020 | GRTX | Galera Therapeutic ... | Sussman Joel F. | Chief Accounting Of ... | Option Exercise | M | 2.43 | 2,639 | 6,413 | 32,238 | |
| Nov 16 2020 | GRTX | Galera Therapeutic ... | Sussman Joel F. | Chief Accounting Of ... | Option Exercise | M | 1.14 | 3,755 | 4,281 | 0 | |
| Nov 16 2020 | GRTX | Galera Therapeutic ... | Sussman Joel F. | Chief Accounting Of ... | Option Exercise | M | 1.07 | 3,606 | 3,858 | 0 | |
| Nov 16 2020 | GRTX | Galera Therapeutic ... | Sussman Joel F. | Chief Accounting Of ... | Option Exercise | M | 1.07 | 10,000 | 10,700 | 3,606 | |
| Nov 16 2020 | GRTX | Galera Therapeutic ... | Sussman Joel F. | Chief Accounting Of ... | Sell | S | 10.32 | 10,000 | 103,197 | 0 | 10 K to 0 (-100.00 %) |
| Nov 16 2020 | GRTX | Galera Therapeutic ... | Sussman Joel F. | Chief Accounting Of ... | Buy | M | 2.43 | 2,639 | 6,413 | 10,000 | 7.4 K to 10 K (+35.85 %) |
| Nov 16 2020 | GRTX | Galera Therapeutic ... | Sussman Joel F. | Chief Accounting Of ... | Buy | M | 1.14 | 3,755 | 4,281 | 7,361 | 3.6 K to 7.4 K (+104.13 %) |
| Nov 16 2020 | GRTX | Galera Therapeutic ... | Sussman Joel F. | Chief Accounting Of ... | Buy | M | 1.07 | 3,606 | 3,858 | 3,606 | 0 to 3.6 K |
| Nov 16 2020 | GRTX | Galera Therapeutic ... | Sussman Joel F. | Chief Accounting Of ... | Sell | S | 10.06 | 10,000 | 100,627 | 0 | 10 K to 0 (-100.00 %) |
| Nov 16 2020 | GRTX | Galera Therapeutic ... | Sussman Joel F. | Chief Accounting Of ... | Buy | M | 1.07 | 10,000 | 10,700 | 10,000 | 0 to 10 K |
| Oct 28 2020 | GRTX | Galera Therapeutic ... | HOLMLUND JON T | Chief Medical Offic ... | Option Exercise | M | 2.43 | 2,244 | 5,453 | 108,898 | |
| Oct 28 2020 | GRTX | Galera Therapeutic ... | HOLMLUND JON T | Chief Medical Offic ... | Sell | S | 15.00 | 2,244 | 33,660 | 0 | 2.2 K to 0 (-100.00 %) |
| Oct 28 2020 | GRTX | Galera Therapeutic ... | HOLMLUND JON T | Chief Medical Offic ... | Buy | M | 2.43 | 2,244 | 5,453 | 2,244 | 0 to 2.2 K |
| Oct 07 2020 | GRTX | Galera Therapeutic ... | HOLMLUND JON T | Chief Medical Offic ... | Option Exercise | M | 1.14 | 5,632 | 6,420 | 0 | |
| Oct 07 2020 | GRTX | Galera Therapeutic ... | HOLMLUND JON T | Chief Medical Offic ... | Option Exercise | M | 1.07 | 4,904 | 5,247 | 0 | |
| Oct 07 2020 | GRTX | Galera Therapeutic ... | HOLMLUND JON T | Chief Medical Offic ... | Option Exercise | M | 1.07 | 100 | 107 | 4,904 | |
| Oct 07 2020 | GRTX | Galera Therapeutic ... | HOLMLUND JON T | Chief Medical Offic ... | Sell | S | 12.00 | 10,536 | 126,432 | 0 | 10.5 K to 0 (-100.00 %) |
| Oct 07 2020 | GRTX | Galera Therapeutic ... | HOLMLUND JON T | Chief Medical Offic ... | Buy | M | 1.14 | 5,632 | 6,420 | 5,632 | 0 to 5.6 K |
| Oct 07 2020 | GRTX | Galera Therapeutic ... | HOLMLUND JON T | Chief Medical Offic ... | Buy | M | 1.07 | 4,904 | 5,247 | 4,904 | 0 to 4.9 K |
| Oct 07 2020 | GRTX | Galera Therapeutic ... | HOLMLUND JON T | Chief Medical Offic ... | Sell | S | 12.00 | 100 | 1,200 | 0 | 100 to 0 (-100.00 %) |
| Oct 07 2020 | GRTX | Galera Therapeutic ... | HOLMLUND JON T | Chief Medical Offic ... | Buy | M | 1.07 | 100 | 107 | 100 | 0 to 100 |
| Jun 22 2020 | GRTX | Galera Therapeutic ... | Novartis Bioventures Ltd | Sell | S | 8.25 | 1,001,312 | 8,260,824 | 2,467,961 | 3.5 M to 2.5 M (-28.86 %) | |
| Jun 22 2020 | GRTX | Galera Therapeutic ... | Novartis Bioventures Ltd | Sell | S | 9.04 | 900 | 8,136 | 3,469,273 | 3.5 M to 3.5 M (-0.03 %) | |
| Jun 22 2020 | GRTX | Galera Therapeutic ... | Novartis Bioventures Ltd | Sell | S | 8.25 | 1,001,312 | 8,260,824 | 2,467,961 | 3.5 M to 2.5 M (-28.86 %) | |
| Jun 22 2020 | GRTX | Galera Therapeutic ... | Novartis Bioventures Ltd | Sell | S | 9.04 | 900 | 8,136 | 3,469,273 | 3.5 M to 3.5 M (-0.03 %) | |
| Jun 17 2020 | GRTX | Galera Therapeutic ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 9.27 | 4,622 | 42,846 | 3,470,173 | 3.5 M to 3.5 M (-0.13 %) |
| Jun 17 2020 | GRTX | Galera Therapeutic ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 9.30 | 8,600 | 79,980 | 3,474,795 | 3.5 M to 3.5 M (-0.25 %) |
| Jun 17 2020 | GRTX | Galera Therapeutic ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 9.05 | 6,164 | 55,784 | 3,483,395 | 3.5 M to 3.5 M (-0.18 %) |
| Jun 12 2020 | GRTX | Galera Therapeutic ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 9.19 | 1,500 | 13,785 | 3,489,559 | 3.5 M to 3.5 M (-0.04 %) |
| Jun 12 2020 | GRTX | Galera Therapeutic ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 9.21 | 7,200 | 66,312 | 3,491,059 | 3.5 M to 3.5 M (-0.21 %) |
| Jun 12 2020 | GRTX | Galera Therapeutic ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 9.46 | 8,532 | 80,713 | 3,498,259 | 3.5 M to 3.5 M (-0.24 %) |
| Jun 10 2020 | GRTX | Galera Therapeutic ... | Cunningham Emmett | Director | Option Exercise | A | 9.31 | 9,888 | 92,057 | 0 | |
| Jun 10 2020 | GRTX | Galera Therapeutic ... | POWELL MICHAEL | Director | Option Exercise | A | 9.31 | 13,179 | 122,696 | 13,179 | |
| Jun 10 2020 | GRTX | Galera Therapeutic ... | Alleva Lawrence M | Director | Option Exercise | A | 9.31 | 9,888 | 92,057 | 9,888 | |
| Jun 10 2020 | GRTX | Galera Therapeutic ... | LOKAY KEVIN G | Director | Option Exercise | A | 9.31 | 9,888 | 92,057 | 9,888 | |
| Jun 09 2020 | GRTX | Galera Therapeutic ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 9.38 | 7,000 | 65,660 | 3,506,791 | 3.5 M to 3.5 M (-0.20 %) |
| Jun 09 2020 | GRTX | Galera Therapeutic ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 9.66 | 5,659 | 54,666 | 3,513,791 | 3.5 M to 3.5 M (-0.16 %) |
| Jun 09 2020 | GRTX | Galera Therapeutic ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 9.66 | 8,652 | 83,578 | 3,519,450 | 3.5 M to 3.5 M (-0.25 %) |
| Jun 04 2020 | GRTX | Galera Therapeutic ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 9.55 | 4,088 | 39,040 | 3,528,102 | 3.5 M to 3.5 M (-0.12 %) |
| Jun 04 2020 | GRTX | Galera Therapeutic ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 9.78 | 5,208 | 50,934 | 3,532,190 | 3.5 M to 3.5 M (-0.15 %) |
| Jun 04 2020 | GRTX | Galera Therapeutic ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 9.68 | 5,669 | 54,876 | 3,537,398 | 3.5 M to 3.5 M (-0.16 %) |
| May 28 2020 | GRTX | Galera Therapeutic ... | HOLMLUND JON T | Chief Medical Offic ... | Option Exercise | M | 1.07 | 692 | 740 | 5,004 | |
| May 28 2020 | GRTX | Galera Therapeutic ... | HOLMLUND JON T | Chief Medical Offic ... | Sell | S | 12.00 | 692 | 8,304 | 0 | 692 to 0 (-100.00 %) |
| May 28 2020 | GRTX | Galera Therapeutic ... | HOLMLUND JON T | Chief Medical Offic ... | Buy | M | 1.07 | 692 | 740 | 692 | 0 to 692 |
| May 28 2020 | GRTX | Galera Therapeutic ... | HOLMLUND JON T | Chief Medical Offic ... | Option Exercise | M | 1.07 | 692 | 740 | 5,004 | |
| May 28 2020 | GRTX | Galera Therapeutic ... | HOLMLUND JON T | Chief Medical Offic ... | Sell | S | 12.00 | 692 | 8,304 | 0 | 692 to 0 (-100.00 %) |
| May 28 2020 | GRTX | Galera Therapeutic ... | HOLMLUND JON T | Chief Medical Offic ... | Buy | M | 1.07 | 692 | 740 | 692 | 0 to 692 |
| May 22 2020 | GRTX | Galera Therapeutic ... | HOLMLUND JON T | Chief Medical Offic ... | Option Exercise | M | 1.07 | 1,174 | 1,256 | 5,696 | |
| May 22 2020 | GRTX | Galera Therapeutic ... | HOLMLUND JON T | Chief Medical Offic ... | Option Exercise | M | 1.07 | 969 | 1,037 | 6,870 | |
| May 22 2020 | GRTX | Galera Therapeutic ... | HOLMLUND JON T | Chief Medical Offic ... | Sell | S | 12.00 | 1,174 | 14,088 | 0 | 1.2 K to 0 (-100.00 %) |
| May 22 2020 | GRTX | Galera Therapeutic ... | HOLMLUND JON T | Chief Medical Offic ... | Buy | M | 1.07 | 1,174 | 1,256 | 1,174 | 0 to 1.2 K |
| May 22 2020 | GRTX | Galera Therapeutic ... | HOLMLUND JON T | Chief Medical Offic ... | Sell | S | 12.00 | 969 | 11,628 | 0 | 969 to 0 (-100.00 %) |
| May 22 2020 | GRTX | Galera Therapeutic ... | HOLMLUND JON T | Chief Medical Offic ... | Buy | M | 1.07 | 969 | 1,037 | 969 | 0 to 969 |
| May 12 2020 | GRTX | Galera Therapeutic ... | HOLMLUND JON T | Chief Medical Offic ... | Option Exercise | M | 1.07 | 671 | 718 | 7,839 | |
| May 12 2020 | GRTX | Galera Therapeutic ... | HOLMLUND JON T | Chief Medical Offic ... | Option Exercise | M | 1.07 | 185 | 198 | 8,510 | |
| May 12 2020 | GRTX | Galera Therapeutic ... | HOLMLUND JON T | Chief Medical Offic ... | Option Exercise | M | 1.07 | 5,102 | 5,459 | 8,695 | |
| May 12 2020 | GRTX | Galera Therapeutic ... | HOLMLUND JON T | Chief Medical Offic ... | Sell | S | 12.00 | 671 | 8,052 | 0 | 671 to 0 (-100.00 %) |
| May 12 2020 | GRTX | Galera Therapeutic ... | HOLMLUND JON T | Chief Medical Offic ... | Buy | M | 1.07 | 671 | 718 | 671 | 0 to 671 |
| May 12 2020 | GRTX | Galera Therapeutic ... | HOLMLUND JON T | Chief Medical Offic ... | Sell | S | 12.00 | 185 | 2,220 | 0 | 185 to 0 (-100.00 %) |
| May 12 2020 | GRTX | Galera Therapeutic ... | HOLMLUND JON T | Chief Medical Offic ... | Buy | M | 1.07 | 185 | 198 | 185 | 0 to 185 |
| May 12 2020 | GRTX | Galera Therapeutic ... | HOLMLUND JON T | Chief Medical Offic ... | Sell | S | 12.00 | 5,102 | 61,224 | 0 | 5.1 K to 0 (-100.00 %) |
| May 12 2020 | GRTX | Galera Therapeutic ... | HOLMLUND JON T | Chief Medical Offic ... | Buy | M | 1.07 | 5,102 | 5,459 | 5,102 | 0 to 5.1 K |
| May 07 2020 | GRTX | Galera Therapeutic ... | HOLMLUND JON T | Chief Medical Offic ... | Option Exercise | M | 1.07 | 2,059 | 2,203 | 13,797 | |
| May 07 2020 | GRTX | Galera Therapeutic ... | HOLMLUND JON T | Chief Medical Offic ... | Option Exercise | M | 1.07 | 1,489 | 1,593 | 15,856 | |
| May 07 2020 | GRTX | Galera Therapeutic ... | HOLMLUND JON T | Chief Medical Offic ... | Option Exercise | M | 1.07 | 3,064 | 3,278 | 17,345 | |
| May 07 2020 | GRTX | Galera Therapeutic ... | HOLMLUND JON T | Chief Medical Offic ... | Sell | S | 12.00 | 2,059 | 24,709 | 0 | 2.1 K to 0 (-100.00 %) |
| May 07 2020 | GRTX | Galera Therapeutic ... | HOLMLUND JON T | Chief Medical Offic ... | Buy | M | 1.07 | 2,059 | 2,203 | 2,059 | 0 to 2.1 K |
| May 07 2020 | GRTX | Galera Therapeutic ... | HOLMLUND JON T | Chief Medical Offic ... | Sell | S | 12.00 | 1,489 | 17,868 | 0 | 1.5 K to 0 (-100.00 %) |
| May 07 2020 | GRTX | Galera Therapeutic ... | HOLMLUND JON T | Chief Medical Offic ... | Buy | M | 1.07 | 1,489 | 1,593 | 1,489 | 0 to 1.5 K |
| May 07 2020 | GRTX | Galera Therapeutic ... | HOLMLUND JON T | Chief Medical Offic ... | Sell | S | 12.16 | 3,064 | 37,258 | 0 | 3.1 K to 0 (-100.00 %) |
| May 07 2020 | GRTX | Galera Therapeutic ... | HOLMLUND JON T | Chief Medical Offic ... | Buy | M | 1.07 | 3,064 | 3,278 | 3,064 | 0 to 3.1 K |
| Apr 02 2020 | GRTX | Galera Therapeutic ... | West Linda | Director | Option Exercise | A | 9.50 | 19,776 | 187,872 | 19,776 | |
| Dec 17 2019 | GRTX | Galera Therapeutic ... | Alleva Lawrence M | Director | Buy | P | 9.78 | 4,000 | 39,139 | 4,000 | 0 to 4 K |
| Nov 14 2019 | GRTX | Galera Therapeutic ... | Clarus IV-A, L.P. | 10% Owner | Option Exercise | C | 0.00 | 561,385 | 0 | 0 | |
| Nov 14 2019 | GRTX | Galera Therapeutic ... | Clarus IV-A, L.P. | 10% Owner | Option Exercise | C | 0.00 | 2,807,372 | 0 | 0 | |
| Nov 14 2019 | GRTX | Galera Therapeutic ... | Clarus IV-A, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,552,035 | 0 | 0 | |
| Nov 14 2019 | GRTX | Galera Therapeutic ... | Clarus IV-A, L.P. | 10% Owner | Option Exercise | C | 0.00 | 2,334,966 | 0 | 0 | |
| Nov 14 2019 | GRTX | Galera Therapeutic ... | Clarus IV-A, L.P. | 10% Owner | Buy | P | 12.00 | 19,423 | 233,076 | 130,444 | 111 K to 130.4 K (+17.49 %) |
| Nov 14 2019 | GRTX | Galera Therapeutic ... | Clarus IV-A, L.P. | 10% Owner | Buy | P | 12.00 | 97,131 | 1,165,572 | 652,324 | 555.2 K to 652.3 K (+17.49 %) |
| Nov 14 2019 | GRTX | Galera Therapeutic ... | Clarus IV-A, L.P. | 10% Owner | Buy | P | 12.00 | 52,660 | 631,920 | 353,661 | 301 K to 353.7 K (+17.49 %) |
| Nov 14 2019 | GRTX | Galera Therapeutic ... | Clarus IV-A, L.P. | 10% Owner | Buy | P | 12.00 | 80,786 | 969,432 | 542,555 | 461.8 K to 542.6 K (+17.49 %) |
| Nov 14 2019 | GRTX | Galera Therapeutic ... | Clarus IV-A, L.P. | 10% Owner | Buy | C | 0.00 | 111,021 | 0 | 111,021 | 0 to 111 K |
| Nov 14 2019 | GRTX | Galera Therapeutic ... | Clarus IV-A, L.P. | 10% Owner | Buy | C | 0.00 | 555,193 | 0 | 555,193 | 0 to 555.2 K |
| Nov 14 2019 | GRTX | Galera Therapeutic ... | Clarus IV-A, L.P. | 10% Owner | Buy | C | 0.00 | 301,001 | 0 | 301,001 | 0 to 301 K |
| Nov 14 2019 | GRTX | Galera Therapeutic ... | Clarus IV-A, L.P. | 10% Owner | Buy | C | 0.00 | 461,769 | 0 | 461,769 | 0 to 461.8 K |
| Nov 14 2019 | GRTX | Galera Therapeutic ... | Blackstone Clarus GP L.P. | 10% Owner | Option Exercise | C | 0.00 | 561,385 | 0 | 0 | |
| Nov 14 2019 | GRTX | Galera Therapeutic ... | Blackstone Clarus GP L.P. | 10% Owner | Option Exercise | C | 0.00 | 2,807,372 | 0 | 0 | |
| Nov 14 2019 | GRTX | Galera Therapeutic ... | Blackstone Clarus GP L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,552,035 | 0 | 0 | |
| Nov 14 2019 | GRTX | Galera Therapeutic ... | Blackstone Clarus GP L.P. | 10% Owner | Option Exercise | C | 0.00 | 2,334,966 | 0 | 0 | |
| Nov 14 2019 | GRTX | Galera Therapeutic ... | Blackstone Clarus GP L.P. | 10% Owner | Buy | P | 12.00 | 19,423 | 233,076 | 130,444 | 111 K to 130.4 K (+17.49 %) |
| Nov 14 2019 | GRTX | Galera Therapeutic ... | Blackstone Clarus GP L.P. | 10% Owner | Buy | P | 12.00 | 97,131 | 1,165,572 | 652,324 | 555.2 K to 652.3 K (+17.49 %) |
| Nov 14 2019 | GRTX | Galera Therapeutic ... | Blackstone Clarus GP L.P. | 10% Owner | Buy | P | 12.00 | 52,660 | 631,920 | 353,661 | 301 K to 353.7 K (+17.49 %) |
| Nov 14 2019 | GRTX | Galera Therapeutic ... | Blackstone Clarus GP L.P. | 10% Owner | Buy | P | 12.00 | 80,786 | 969,432 | 542,555 | 461.8 K to 542.6 K (+17.49 %) |
| Nov 14 2019 | GRTX | Galera Therapeutic ... | Blackstone Clarus GP L.P. | 10% Owner | Buy | C | 0.00 | 111,021 | 0 | 111,021 | 0 to 111 K |
| Nov 14 2019 | GRTX | Galera Therapeutic ... | Blackstone Clarus GP L.P. | 10% Owner | Buy | C | 0.00 | 555,193 | 0 | 555,193 | 0 to 555.2 K |
| Nov 14 2019 | GRTX | Galera Therapeutic ... | Blackstone Clarus GP L.P. | 10% Owner | Buy | C | 0.00 | 301,001 | 0 | 301,001 | 0 to 301 K |
| Nov 14 2019 | GRTX | Galera Therapeutic ... | Blackstone Clarus GP L.P. | 10% Owner | Buy | C | 0.00 | 461,769 | 0 | 461,769 | 0 to 461.8 K |
| Nov 14 2019 | GRTX | Galera Therapeutic ... | Novo Holdings A/S | 10% Owner | Option Exercise | C | 0.00 | 2,709,659 | 0 | 0 | |
| Nov 14 2019 | GRTX | Galera Therapeutic ... | Novo Holdings A/S | 10% Owner | Option Exercise | C | 0.00 | 12,000,000 | 0 | 0 | |
| Nov 14 2019 | GRTX | Galera Therapeutic ... | Novo Holdings A/S | 10% Owner | Buy | P | 12.00 | 500,000 | 6,000,000 | 3,409,021 | 2.9 M to 3.4 M (+17.19 %) |
| Nov 14 2019 | GRTX | Galera Therapeutic ... | Novo Holdings A/S | 10% Owner | Buy | C | 0.00 | 535,869 | 0 | 2,909,021 | 2.4 M to 2.9 M (+22.58 %) |
| Nov 14 2019 | GRTX | Galera Therapeutic ... | Novo Holdings A/S | 10% Owner | Buy | C | 0.00 | 2,373,152 | 0 | 2,373,152 | 0 to 2.4 M |
| Nov 12 2019 | GRTX | Galera Therapeutic ... | New Enterprise Associates 14, ... | 10% Owner | Option Exercise | C | 0.00 | 1,354,829 | 0 | 0 | |
| Nov 12 2019 | GRTX | Galera Therapeutic ... | New Enterprise Associates 14, ... | 10% Owner | Option Exercise | C | 0.00 | 9,600,000 | 0 | 0 | |
| Nov 12 2019 | GRTX | Galera Therapeutic ... | New Enterprise Associates 14, ... | 10% Owner | Option Exercise | C | 0.00 | 8,975,000 | 0 | 0 | |
| Nov 12 2019 | GRTX | Galera Therapeutic ... | New Enterprise Associates 14, ... | 10% Owner | Buy | P | 12.00 | 416,666 | 4,999,992 | 4,358,047 | 3.9 M to 4.4 M (+10.57 %) |
| Nov 12 2019 | GRTX | Galera Therapeutic ... | New Enterprise Associates 14, ... | 10% Owner | Buy | C | 0.00 | 267,935 | 0 | 3,941,381 | 3.7 M to 3.9 M (+7.29 %) |
| Nov 12 2019 | GRTX | Galera Therapeutic ... | New Enterprise Associates 14, ... | 10% Owner | Buy | C | 0.00 | 1,898,524 | 0 | 3,673,446 | 1.8 M to 3.7 M (+106.96 %) |
| Nov 12 2019 | GRTX | Galera Therapeutic ... | New Enterprise Associates 14, ... | 10% Owner | Buy | C | 0.00 | 1,774,922 | 0 | 1,774,922 | 0 to 1.8 M |
| Nov 12 2019 | GRTX | Galera Therapeutic ... | Novartis Bioventures Ltd | 10% Owner | Option Exercise | C | 0.00 | 451,609 | 0 | 0 | |
| Nov 12 2019 | GRTX | Galera Therapeutic ... | Novartis Bioventures Ltd | 10% Owner | Option Exercise | C | 0.00 | 7,200,000 | 0 | 0 | |
| Nov 12 2019 | GRTX | Galera Therapeutic ... | Novartis Bioventures Ltd | 10% Owner | Option Exercise | C | 0.00 | 9,000,000 | 0 | 0 | |
| Nov 12 2019 | GRTX | Galera Therapeutic ... | Novartis Bioventures Ltd | 10% Owner | Buy | P | 12.00 | 250,000 | 3,000,000 | 3,543,067 | 3.3 M to 3.5 M (+7.59 %) |
| Nov 12 2019 | GRTX | Galera Therapeutic ... | Novartis Bioventures Ltd | 10% Owner | Buy | C | 0.00 | 3,293,067 | 0 | 3,293,067 | 0 to 3.3 M |
| Nov 12 2019 | GRTX | Galera Therapeutic ... | Beardsley Robert A | Chief Operating Off ... | Option Exercise | C | 0.00 | 6,774 | 0 | 0 | |
| Nov 12 2019 | GRTX | Galera Therapeutic ... | Beardsley Robert A | Chief Operating Off ... | Option Exercise | C | 0.00 | 2,000 | 0 | 0 | |
| Nov 12 2019 | GRTX | Galera Therapeutic ... | Beardsley Robert A | Chief Operating Off ... | Option Exercise | C | 0.00 | 68,907 | 0 | 0 | |
| Nov 12 2019 | GRTX | Galera Therapeutic ... | Beardsley Robert A | Chief Operating Off ... | Buy | C | 0.00 | 15,361 | 0 | 68,191 | 52.8 K to 68.2 K (+29.08 %) |
| Nov 08 2019 | GRTX | Galera Therapeutic ... | Fuller Jason | Director | Option Exercise | A | 12.00 | 19,776 | 237,312 | 19,776 | |
| Nov 08 2019 | GRTX | Galera Therapeutic ... | Blackstone Group Inc | 10% Owner | Option Exercise | J | 12.00 | 19,776 | 237,312 | 0 | |
| Nov 08 2019 | GRTX | Galera Therapeutic ... | Cunningham Emmett | Director | Option Exercise | A | 12.00 | 19,776 | 237,312 | 0 | |
| Nov 08 2019 | GRTX | Galera Therapeutic ... | POWELL MICHAEL | Director | Option Exercise | A | 12.00 | 19,776 | 237,312 | 19,776 | |
| Nov 08 2019 | GRTX | Galera Therapeutic ... | Degnan Chris | Chief Financial Off ... | Option Exercise | A | 12.00 | 229,513 | 2,754,156 | 229,513 |
Page: 1